// App-Quantinova.ai

3035 : Exploration of baseline derived neutrophil to lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) treated with immune checkpoint inhibitors (ICI) or cytotoxic chemotherapy (CCT).

Researchers

Presenter

  • Dickran Garo Kazandjian

Principal Investigators

  • Yutao Gong

  • Haykanush Kazandjian

  • Richard Pazdur

  • Gideon Michael Blumenthal

Medical Centers

  • Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

  • U.S. Food and Drug Administration, Silver Spring, MD

  • Montgomery College, Takoma Park, MD

  • U.S. Food and Drug Administration, Silver Spring, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved